QIAGEN launches Oncology Molecular Profiling Services in Europe

QIAGEN builds on global collaboration with Amgen for companion diagnostic development in non-small cell lung cancer

QIAGEN celebrates surpassing 2,500 cumulative placements of QIAsymphony 

QIAGEN’s QuantiFERON®-TB Gold Plus gains approval in Canada

QIAGEN unveils plans for next-generation digital PCR systems

QIAGEN to develop QuantiFERON®-TB Access as a new test for low-resource, high-burden regions in global fight against TB

QIAGEN launches QIAcube Connect – next-generation automation for sample processing in research labs

QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support

QIAGEN provides status update on settlement mechanics of convertible notes

QIAGEN receives approval for EGFR test in lung cancer as companion diagnostic in Japan